Document is current

Article History

Received: 17 August 2022

Accepted: 1 February 2024

First Online: 17 February 2024

Declarations

:

: This study was approved by the Ethics Committee of Tangdu Hospital on 25 August 2021 (NO. K202108-25). The study was approved by the Ethics Committee of four trial-hosting hospitals on 20 August 2021 (No. K202108-25, X2Y202210, KY2002-0003, SZFYIEC-PJ-2022[78]). This manuscript is based on V.1.2, 20 August 2021, of the protocol. Research staff will obtain informed consent from every participant prior to the study. On the consent form, participants will be asked if they agree to use their data and if they choose to withdraw from the trial. Participants will also be asked to permit the research team to share relevant data with people from other academic institutes who take part in the research or persons from relevant regulatory authorities. This trial does not involve collecting biological specimens for storage. There is no anticipated harm and compensation for trial participation. Post-trial free consultation will be provided for participants at least 12 months.

: Information of participants in this study is strictly confidential. Any information that is published will not reveal the identity of the subjects. The study results will be disseminated in peer-reviewed journal publications and academic conference presentations.

: The authors declare that they have no competing interests.